FDA panel reviewing Abbott heart device had 10 doctors with financial ties to suburban Chicago health giant

The FDA said nothing about the payments from the North Chicago company when the panel met to assess new technology, a "breakthrough device" for which the agency "may be willing to accept greater uncertainty" when considering risks and benefits.

Related Keywords

Boston ,Massachusetts ,United States ,Marc Katz ,Craig Selzman ,Audra Harrison ,Paul Hauptman ,Joel Perlmutter ,Megan Naber ,Brent Tippen ,Mitchell Krucoff ,Diana Zuckerman ,John Hirshfeld Jr ,Drug Administration ,University Of South Carolina ,University Of Pennsylvania ,University Of Utah Hospitals Clinics ,Duke University School Of Medicine ,Department Of Health ,Division Of Cardiothoracic Surgery ,Washington University School Of Medicine ,Human Services ,Health Research ,Reno School Of Medicine ,Health News ,University Of Utah ,University Of Nevada ,Cardiovascular Research Foundation ,Pfizer ,National Center ,North Chicago Based Abbott ,Open Payments ,Washington University School ,Cardiothoracic Surgery ,Utah Hospitals ,Nevada Reno School ,Medical University ,South Carolina ,Duke University School ,